Prosight Management’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-107,560
Closed -$1.93M 43
2019
Q1
$1.93M Sell
107,560
-86,569
-45% -$1.5M 0.85% 30
2018
Q4
$2.46M Sell
194,129
-263,346
-58% -$4.42M 1.27% 25
2018
Q3
$9.81M Sell
457,475
-161,040
-26% -$3.43M 5.47% 4
2018
Q2
$12.8M Buy
618,515
+173,515
+39% +$3.91M 9.36% 2
2018
Q1
$11.2M Sell
445,000
-162,696
-27% -$3.95M 7.02% 3
2017
Q4
$11.5M Buy
+607,696
New +$11.3M 8.49% 2

Other funds holding MGNX

Prosight Management's MGNX Position: Q2 2019 in Review

Prosight Management sold out of MacroGenics (MGNX) in Q2 2019, closing a stake of 107,560 shares — an estimated $1.93M sold.

Prosight Management first reported a position in MGNX in Q4 2017 and held it in 6 quarters. The position peaked at $12.8M in Q2 2018. 130 funds tracked by Wall St. Rank hold MGNX as of Q2 2019.

  • Prosight Management reported no remaining MacroGenics position as of Q2 2019 after selling out during the quarter.
  • Prosight Management sold 107,560 MacroGenics shares in Q2 2019, an estimated $1.93M.
  • Prosight Management first reported a position in MacroGenics in Q4 2017 and held it in 6 quarters.
  • Prosight Management's MacroGenics position peaked at $12.8M in Q2 2018.
  • 130 funds tracked by Wall St. Rank held MacroGenics as of Q2 2019.

Based on Prosight Management's 13F filing for Q2 2019, filed 14 Aug 2019.